Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cure-Allergic Rhinitis Syrup
- Development stage
- Phase 2
- Lead developer
- The Hong Kong Polytechnic University
- Administration
- Oral
01
Overview
Cure-Allergic Rhinitis Syrup is a Chinese herbal medicine formulation developed for the treatment of allergic rhinitis (AR). It was specifically evaluated in a randomized controlled trial conducted by The Hong Kong Polytechnic University, targeting nursing students with AR and a Cold/Yang-Deficiency body constitution. The syrup is designed to alleviate AR symptoms, improve body constitution patterns, and enhance health-related quality of life. In clinical studies, its efficacy has been compared to the traditional formula Yu-ping-fung San and a placebo.
- Other names
- Cure-Allergic
Beyond the preview
Go deeper on Cure-Allergic Rhinitis Syrup.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cure-Allergic Rhinitis Syrup.